These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23208013)

  • 1. MCARD-mediated gene transfer of GRK2 inhibitor in ovine model of acute myocardial infarction.
    Swain JD; Fargnoli AS; Katz MG; Tomasulo CE; Sumaroka M; Richardville KC; Koch WJ; Rabinowitz JE; Bridges CR
    J Cardiovasc Transl Res; 2013 Apr; 6(2):253-62. PubMed ID: 23208013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AAV6-βARKct gene delivery mediated by molecular cardiac surgery with recirculating delivery (MCARD) in sheep results in robust gene expression and increased adrenergic reserve.
    Katz MG; Fargnoli AS; Swain JD; Tomasulo CE; Ciccarelli M; Huang ZM; Rabinowitz JE; Bridges CR
    J Thorac Cardiovasc Surg; 2012 Mar; 143(3):720-726.e3. PubMed ID: 22143102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of high-dose adeno-associated virus 9 encoding sarcoplasmic reticulum Ca(2+) adenosine triphosphatase delivered by molecular cardiac surgery with recirculating delivery in ovine ischemic cardiomyopathy.
    Katz MG; Fargnoli AS; Williams RD; Steuerwald NM; Isidro A; Ivanina AV; Sokolova IM; Bridges CR
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1065-72, 1073e1-2; discussion1072-3. PubMed ID: 25037619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AAV6.βARKct cardiac gene therapy ameliorates cardiac function and normalizes the catecholaminergic axis in a clinically relevant large animal heart failure model.
    Raake PW; Schlegel P; Ksienzyk J; Reinkober J; Barthelmes J; Schinkel S; Pleger S; Mier W; Haberkorn U; Koch WJ; Katus HA; Most P; Müller OJ
    Eur Heart J; 2013 May; 34(19):1437-47. PubMed ID: 22261894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac-selective expression of extracellular superoxide dismutase after systemic injection of adeno-associated virus 9 protects the heart against post-myocardial infarction left ventricular remodeling.
    Konkalmatt PR; Beyers RJ; O'Connor DM; Xu Y; Seaman ME; French BA
    Circ Cardiovasc Imaging; 2013 May; 6(3):478-86. PubMed ID: 23536266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GRK2 blockade with βARKct is essential for cardiac β2-adrenergic receptor signaling towards increased contractility.
    Salazar NC; Vallejos X; Siryk A; Rengo G; Cannavo A; Liccardo D; De Lucia C; Gao E; Leosco D; Koch WJ; Lymperopoulos A
    Cell Commun Signal; 2013 Aug; 11():64. PubMed ID: 23984976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac progenitor cells engineered with βARKct have enhanced β-adrenergic tolerance.
    Khan M; Mohsin S; Toko H; Alkatib M; Nguyen J; Truffa S; Gude N; Chuprun K; Tilley DG; Koch WJ; Sussman MA
    Mol Ther; 2014 Jan; 22(1):178-85. PubMed ID: 24002692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventricular dysfunction after cardioplegic arrest is improved after myocardial gene transfer of a beta-adrenergic receptor kinase inhibitor.
    Tevaearai HT; Eckhart AD; Shotwell KF; Wilson K; Koch WJ
    Circulation; 2001 Oct; 104(17):2069-74. PubMed ID: 11673348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo ventricular gene delivery of a beta-adrenergic receptor kinase inhibitor to the failing heart reverses cardiac dysfunction.
    Shah AS; White DC; Emani S; Kypson AP; Lilly RE; Wilson K; Glower DD; Lefkowitz RJ; Koch WJ
    Circulation; 2001 Mar; 103(9):1311-6. PubMed ID: 11238278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial adeno-associated virus serotype 6-betaARKct gene therapy improves cardiac function and normalizes the neurohormonal axis in chronic heart failure.
    Rengo G; Lymperopoulos A; Zincarelli C; Donniacuo M; Soltys S; Rabinowitz JE; Koch WJ
    Circulation; 2009 Jan; 119(1):89-98. PubMed ID: 19103992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G protein-coupled receptor kinase 2 ablation in cardiac myocytes before or after myocardial infarction prevents heart failure.
    Raake PW; Vinge LE; Gao E; Boucher M; Rengo G; Chen X; DeGeorge BR; Matkovich S; Houser SR; Most P; Eckhart AD; Dorn GW; Koch WJ
    Circ Res; 2008 Aug; 103(4):413-22. PubMed ID: 18635825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac surgical delivery of the sarcoplasmic reticulum calcium ATPase rescues myocytes in ischemic heart failure.
    Fargnoli AS; Katz MG; Yarnall C; Isidro A; Petrov M; Steuerwald N; Ghosh S; Richardville KC; Hillesheim R; Williams RD; Kohlbrenner E; Stedman HH; Hajjar RJ; Bridges CR
    Ann Thorac Surg; 2013 Aug; 96(2):586-95. PubMed ID: 23773730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AAV9.I-1c delivered via direct coronary infusion in a porcine model of heart failure improves contractility and mitigates adverse remodeling.
    Fish KM; Ladage D; Kawase Y; Karakikes I; Jeong D; Ly H; Ishikawa K; Hadri L; Tilemann L; Muller-Ehmsen J; Samulski RJ; Kranias EG; Hajjar RJ
    Circ Heart Fail; 2013 Mar; 6(2):310-7. PubMed ID: 23271792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infarct size reduction and attenuation of global left ventricular remodeling with the CorCap cardiac support device following acute myocardial infarction in sheep.
    Blom AS; Pilla JJ; Gorman RC; Gorman JH; Mukherjee R; Spinale FG; Acker MA
    Heart Fail Rev; 2005 Jun; 10(2):125-39. PubMed ID: 16258720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute ischemic cardiac dysfunction is attenuated via gene transfer of a peptide inhibitor of the beta-adrenergic receptor kinase (betaARK1).
    Tevaearai HT; Walton GB; Keys JR; Koch WJ; Eckhart AD
    J Gene Med; 2005 Sep; 7(9):1172-7. PubMed ID: 15880449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spacial and Temporal Patterns of Gene Expression After Cardiac MEK1 Gene Transfer Improve Post-Infarction Remodeling Without Inducing Global Hypertrophy.
    Fan Y; Yang YL; Yeh CC; Mann MJ
    J Cell Biochem; 2017 Apr; 118(4):775-784. PubMed ID: 27639174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial gene delivery using molecular cardiac surgery with recombinant adeno-associated virus vectors in vivo.
    White JD; Thesier DM; Swain JB; Katz MG; Tomasulo C; Henderson A; Wang L; Yarnall C; Fargnoli A; Sumaroka M; Isidro A; Petrov M; Holt D; Nolen-Walston R; Koch WJ; Stedman HH; Rabinowitz J; Bridges CR
    Gene Ther; 2011 Jun; 18(6):546-52. PubMed ID: 21228882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paroxetine-mediated GRK2 inhibition reverses cardiac dysfunction and remodeling after myocardial infarction.
    Schumacher SM; Gao E; Zhu W; Chen X; Chuprun JK; Feldman AM; Tesmer JJ; Koch WJ
    Sci Transl Med; 2015 Mar; 7(277):277ra31. PubMed ID: 25739765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility to systolic dysfunction in the myocardium from chronically infarcted spontaneously hypertensive rats.
    Norton GR; Veliotes DG; Osadchii O; Woodiwiss AJ; Thomas DP
    Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H372-8. PubMed ID: 17993597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled release of matrix metalloproteinase-1 plasmid DNA prevents left ventricular remodeling in chronic myocardial infarction of rats.
    Lin X; Jo H; Ishii TM; Fujita M; Fu M; Tambara K; Yamamoto M; Tabata Y; Komeda M; Matsuoka S
    Circ J; 2009 Dec; 73(12):2315-21. PubMed ID: 19797822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.